DiePharmazie 7/2017


Original articles

Schulz U, Grossmann A, Wilde F, Freitag M, Lemmerhirt C, Schulzke C, Link A, Morgenstern O: Synthesis, chemical behavior, structure elucidation and iNOS inhibitory activity of 1-substituted 3-methylsulfanyl-5,6,7,8-tetrahydro-1H-[1,2,4]-triazolo[1,2-a]pyridazines
doi: 10.1691/ph.2017.6902 (pp. 371-382)


Rodrigues FF, Braz WR, Perasoli FB, Ferreira LGR, De O. Barbosa LA, Da Silva GR: Implants composed of digoxin and poly(ε-caprolactone): development, characterization, anti-proliferative and anti-angiogenic activities
doi: 10.1691/ph.2017.6195 (pp. 383-388)


Gulsun T, Ozturk N, Kaynak MS, Vural I, Sahin S: Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression
doi: 10.1691/ph.2017.6149 (pp. 389-394)


Hong Qi, Junhua Wang, Fenghua Wang, Hongmei Ma: Long non-coding RNA SNHG1 promotes cell proliferation and tumorigenesis in colorectal cancer via Wnt/β-catenin signaling
doi: 10.1691/ph.2017.7463 (pp. 395-401)


Jinjin Yuan, Zongwen Liu, Rui Song: Antisense IncRNA As-SLC7A11 suppresses epithelial ovarian cancer progression mainly by targeting SLC7A11
doi: 10.1691/ph.2017.7449 (pp. 402-407)


Ji SQ, Zhang YX, Yang BH: UBR5 promotes cell proliferation and inhibits apoptosis in colon cancer by destablizing P21
doi: 10.1691/ph.2017.7433 (pp. 408-413)


Ran Ding, Xianhua Cai, Feng Xu, Huasong Wang, Baocheng Zhang: p63 protects chondrosarcoma malignancies mainly by enhancing the expression of PTEN
doi: 10.1691/ph.2017.6400 (pp. 414-418)


Bo Liu, Yu Zhou, Xia Chen, Dan Peng: IL-1β-mediated NF-κB signaling augments the osteosarcoma cell growth through modulating miR-376c/TGFA axis
doi: 10.1691/ph.2017.6888 (pp. 419-424)


Guang Zhou, Xiaoqin Mao, Jiaqi Chu, Gang Chen, Qiang Zhao, Leili Wang, Yanping Luo: ATP binding cassette subfamily A member 7 rs3764650 polymorphism and the risk of Alzheimer’s disease
doi: 10.1691/ph.2017.6862 (pp. 425-427)


Yoshida S, Suzuki K, Suzuki A, Okada H, Niwa T, Kobayashi R, Murakami N, Ogura S, Itoh Y: Risk factors for the failure of treatment of Pseudomonas aeruginosa bacteremia in critically ill patients

doi: 10.1691/ph.2017.7453 (pp. 428-432)